From “Impossible” to “No Verification Needed”: How WuXi AppTec Earns Client Trust

Trust isn’t built in a day. It grows slowly, project by project, with consistent quality and efficiency. At WuXi AppTec,this is what everyday collaboration looks like: teams and clients achieving more together.

Several years ago, a client that was in negotiations to license a promising drug from a biotech company requested WuXi STA, a subsidiary of WuXI AppTec, to handle the manufacturing.

The synthesis of this molecule posed challenges: a single reaction step took nearly 20 days, the process was prone to side reactions, and yields fluctuated. In just two months, the WuXi STA team resolved the technical difficulties in the synthetic route through systematic analysis and process optimization, successfully completing technology mobilization and process qualification.

When the project timeline was presented, however, the biotech company’s reaction was not what anyone expected.

“That’s impossible,” the leadership team stated bluntly. “Your proposed timeline is nearly three times faster than our current vendor. Either the quality will suffer, or you’re exaggerating.”

Rather than defending their credibility with words, the project team turned to scientific demonstration.  

They quickly produced a batch of samples for verification. The synthesis involved 10 reaction steps in total. After each step, the intermediate was sent to an independent lab designated by the biotech company for testing and release before the next step proceeded.

The biotech company’s approval came sooner than expected. Well before the end of the experiment, the biotech company was convinced: “No need for further verification. Let’s move on,” they said.

From then on, doubt gave way to trust, and the project moved forward. 

Leveraging Integrated Platform Capabilities to Overcome Key Challenges

A year later, the project had progressed to Process Performance Qualification (PPQ) manufacturing. Leveraging the integrated CRDMO platform, the project team partnered closely with the client to formulate a feasible plan and proactively identify potential risks. Despite tight deadlines and diverse requirements, they overcame multiple technical hurdles and made steady progress.

During process development, a key challenge was drying an intermediate to remove residual solvents in the original process. Leveraging their manufacturing experience and process platform, the team introduced a series of optimizations that brought residual solvents within specifications in a single drying pass—eliminating the need for the previously time-consuming drying cycles and significantly improving efficiency.

In analytical development, the team respected the client's dedication to their original analytical methods while strictly following the regulatory requirements of different regions. Leveraging the company's integrated analytical platform, they efficiently carried out over 50 method validations and verifications, standardized and structurally confirmed around 30 reference standards and impurities, and performed more than 10 stability and forced degradation studies. This comprehensive work provided solid support for advancing the project.

In just seven months, the team delivered the PPQ batches with “zero deviation” in quality and stability through close collaboration across process R&D, manufacturing, and analytics.

When the project reached the NDA submission stage, the team received the expected request for supplemental information. Because the project used submission materials based on another region, and regulatory standards vary by jurisdiction, more than a dozen items—mainly concerning manufacturing processes and analytical methods—required supplementation or revision during the review. Normally, that would take five months. But because the turnaround time for supplemental responses directly affected the launch date, the client was concerned about how quickly the team could move.

Leveraging the company’s integrated platform and the project team’s extensive experience, the team ensures efficient project execution through close client communication and seamless collaboration between process development and analytical development teams. They wrapped up impurity synthesis, purge studies, method development and validation, and batch analyses in just two months, on schedule for the submission.

The client was impressed by the team’s reliable execution and fast problem solving at key moments. “WuXi AppTec is one of the few that could have done this job,” they said.

With Each Trust, a Fresh Start

Over the years, ownership of this drug changed several times. But no matter who owned it, the WuXi AppTec team was always the one they trusted for subsequent development and manufacturing.

The partnership started with doubt, but over time it turned into trust that has lasted through every change.

Trust like this doesn’t happen by accident. Over the years, every step has been executed reliably and every issue has been addressed quickly. Behind it is the strength of WuXi AppTec’s integrated platform and the team’s deep expertise. This kind of close collaboration and shared success has transformed every delivery from a mere promise kept into a long‑standing partnership built on trust.

This is not an isolated case. It shows the technical expertise and capabilities that the WuXi AppTec team has built over years of challenging projects. For over twenty years, the company has turned many new clients into long-term partners by delivering on time with quality assurance. They have always treated every moment of trust as a fresh start. With its integrated, end-to-end CRDMO platform, WuXi AppTec will continue to enable clients worldwide to turn scientific innovations into treatments that benefit patients.